SEARCH

SEARCH BY CITATION

References

  • Abdel-Malek, Z.A., Scott, M.C., Furumura, M., Lamoreux, M.L., Ollmann, M., Barsh, G.S., and Hearing, V.J. (2001). The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J. Cell Sci. 114, 10191024.
  • Adachi, S., Morii, E., Kim, D., Ogihara, H., Jippo, T., Ito, A., Lee, Y.M., and Kitamura, Y. (2000). Involvement of mi-transcription factor in expression of alpha-melanocyte-stimulating hormone receptor in cultured mast cells of mice. J. Immunol. 164, 855860.
  • Adalsteinsson, S., Hersteinsson, P., and Gunnarsson, E. (1987). Fox colors in relation to colors in mice and sheep. J. Hered. 78, 235237.
  • Adams, G., Olivier, G.W., Branch, S.K., Moss, S.H., Notarianni, L.J., and Pouton, C.W. (1993). Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells. Ann. N. Y. Acad. Sci. 680, 440441.
  • Angers, S., Salahpour, A., and Bouvier, M. (2002). Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409435.
  • Aoki, H., and Moro, O. (2002). Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci. 71, 21712179.
  • Baig, A.H., Swords, F.M., Noon, L.A., King, P.J., Hunyady, L., and Clark, A.J.L. (2001). Desensitization of the Y1 cell adrenocorticotropin receptor. Evidence for a restricted heterologous mechanism implying a role foe receptor–effector complexes. J. Biol. Chem. 276, 4479244797.
  • Bastiaens, M.T., ter Huurne, J.A., Kielich, C., Gruis, N.A., Westendorp, R.G., Vermeer, B.J., and Bavinck, J.N. (2001). Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am. J. Hum. Genet. 68, 884894.
  • Bataille, V. (2003). Genetic epidemiology of melanoma. Eur. J. Cancer 39, 13411347.
  • Beaumont, K.A., Newton, R.A., Smit, D.J., Helen, L.J., Stow, J.L., and Sturm, R.A. (2005). Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum. Mol. Genet. 14, 21452154.
  • Bennett, D.C., and Lamoreux, M.L. (2003). The color loci of mice – a genetic century. Pigment Cell Res. 16, 333344.
  • Biebermann, H., Krude, H., Elsner, A., Chubanov, V., Gudermann, T., and Gruters, A. (2003). Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52, 29842988.
  • Bohm, M., Wolff, I., Scholzen, T.E., Robinson, S.J., Healy, E., Luger, T.A., Schwarz, T., and Schwarz, A. (2005). α -melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280, 57955802.
  • Bolognia, J., Murray, M., and Pawelek, J. (1989). UVB-induced melanogenesis may be mediated through the MSH-receptor system. J. Invest. Dermatol. 92, 651656.
  • Box, N.F., Wyeth, J.R., O'Gorman, L.E., Martin, N.G., and Sturm, R.A. (1997). Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum. Mol. Genet. 6, 18911897.
  • Breitwieser, G.E. (2004). G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. Circ. Res. 94, 1727.
  • Bultman, S.J., Michaud, E.J., and Woychik, R.P. (1992). Molecular characterization of the mouse agouti locus. Cell 71, 11951204.
  • Busca, R., and Ballotti, R. (2000). Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 6069.
  • Chakraborty, A.K., Orlow, S.J., Bolognia, J.L., and Pawelek, J.M. (1991). Structural/functional relationships between internal and external MSH receptors: modulation of expression in Cloudman melanoma cells by UVB radiation. J. Cell. Physiol. 147, 16.
  • Chakraborty, A.K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J.M., and Ichihashi, M. (1996). Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta 1313, 130138.
  • Chakraborty, A.K., Funasaka, Y., Pawelek, J.M., Nagahama, M., Ito, A., and Ichihashi, M. (1999). Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J. Invest. Dermatol. 112, 853860.
  • Chen, G., Way, J., Armour, S., Watson, C., Queen, K., Jayawickreme, C.K., Chen, W.J., and Kenakin, T. (2000). Use of constitutive G protein-coupled receptor activity for drug discovery. Mol. Pharmacol. 57, 125134.
  • Chhajlani, V., and Wikberg, J.E. (1992). Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309, 417420.
  • Chhajlani, V., Xu, X., Blauw, J., and Sudarshi, S. (1996). Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor. Biochem. Biophys. Res. Commun. 219, 521525.
  • Chluba-de Tapia, J., Bagutti, C., Cotti, R., and Eberle, A.N. (1996). Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene. J. Cell Sci. 109 (Pt 8), 20232030.
  • Cone, R.D., Lu, D., Koppula, S., Vage, D.I., Klungland, H., Boston, B., Chen, W., Orth, D.N., Pouton, C., and Kesterson, R.A. (1996). The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog. Horm. Res. 51, 287317.
  • Conklin, B.R., and Bourne, H.R. (1993). Mouse coat colour reconsidered. Nature 364, 110.
  • Corre, S., Primot, A., Sviderskaya, E., Bennett, D.C., Vaulont, S., Goding, C.R., and Galibert, M.D. (2004). UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1). J. Biol. Chem. 279, 5122651233.
  • Donatien, P.D., Hunt, G., Pieron, C., Lunec, J., Taieb, A., and Thody, A.J. (1992). The expression of functional MSH receptors on cultured human melanocytes. Arch. Dermatol. Res. 284, 424426.
  • Duffy, D.L., Box, N.F., Chen, W., Palmer, J.S., Montgomery, G.W., James, M.R., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2004). Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum. Mol. Genet. 13, 447461.
  • Elliott, R.J., Szabo, M., Wagner, M.J., Kemp, E.H., MacNeil, S., and Haycock, J.W. (2004). alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J. Invest. Dermatol. 122, 10101019.
  • Ermak, G., and Slominski, A. (1997). Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J. Invest. Dermatol. 108, 160165.
  • Eves, P., Haycock, J., Layton, C. et al. (2003). Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. Br. J. Cancer 89, 20042015.
  • Fargnoli, M.C., Chimenti, S., Keller, G., Hofler, H., and Peris, K. (2003). Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum. Mutat. 21, 655.
  • Frandberg, P.A., Doufexis, M., Kapas, S., and Chhajlani, V. (1998). Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor. Biochem. Biophys. Res. Commun. 245, 490492.
  • Frandberg, P.A., Doufexis, M., Kapas, S., and Chhajlani, V. (2001). Cysteine residues are involved in structure and function of melanocortin 1 receptor: substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Biochem. Biophys. Res. Commun. 281, 851857.
  • Funasaka, Y., Chakraborty, A.K., Hayashi, Y., Komoto, M., Ohashi, A., Nagahama, M., Inoue, Y., Pawelek, J., and Ichihashi, M. (1998). Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. Br. J. Dermatol. 139, 216224.
  • Gantz, I., and Fong, T.M. (2003). The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 284, E468E474.
  • Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S.J., DelValle, J., and Yamada, T. (1993a). Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268, 82468250.
  • Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S.J., DelValle, J., and Yamada, T. (1993b). Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268, 1517415179.
  • Garg, A.K., and Aggarwal, B.B. (2002). Reactive oxygen intermediates in TNF signaling. Mol. Immunol. 39, 509517.
  • Geschwind, I.I. (1966). Change in hair color in mice induced by injection of alpha-MSH. Endocrinology 79, 11651167.
  • Gether, U. (2000). Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21, 90113.
  • Ghanem, G.E., Comunale, G., Libert, A., Vercammen, G., and Lejeune, F.J. (1988). Evidence for alpha-melanocyte-stimulating hormone (alpha-MSH) receptors on human malignant melanoma cells. Int. J. Cancer 41, 248255.
  • Graham, A., Wakamatsu, K., Hunt, G., Ito, S., and Thody, A.J. (1997). Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone. Pigment Cell Res. 10, 298303.
  • Harding, R.M., Healy, E., Ray, A.J. et al. (2000). Evidence for variable selective pressures at MC1R. Am. J. Hum. Genet. 66, 13511361.
  • Haskell-Luevano, C., Sawyer, T.K., Trumpp-Kallmeyer, S., Bikker, J.A., Humblet, C., Gantz, I., and Hruby, V.J. (1996). Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Drug Des. Discov. 14, 197211.
  • Healy, E. (2004). Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility. Photodermatol. Photoimmunol. Photomed. 20, 283288.
  • Healy, E., Flannagan, N., Ray, A., Todd, C., Jackson, I.J., Matthews, J.N., Birch-Machin, M.A., and Rees, J.L. (2000). Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355, 10721073.
  • Healy, E., Jordan, S.A., Budd, P.S., Suffolk, R., Rees, J.L., and Jackson, I.J. (2001). Functional variation of MC1R alleles from red-haired individuals. Hum. Mol. Genet. 10, 23972402.
  • Holder, J.R., and Haskell-Luevano, C. (2004). Melanocortin ligands: 30 years of structure–activity relationship (SAR) studies. Med. Res. Rev. 24, 325356.
  • Holst, B., and Schwartz, T.W. (2003). Molecular mechanism of agonism and inverse agonism in the melanocortin receptors: Zn(2+) as a structural and functional probe. Ann. N. Y. Acad. Sci. 994, 111.
  • Holst, B., Elling, C.E., and Schwartz, T.W. (2002). Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J. Biol. Chem. 277, 4766247670.
  • Hoogduijn, M.J., McGurk, S., Smit, N.P., Nibbering, P.H., Ancans, J., van der Laarse, A., and Thody, A.J. (2002). Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I). Biochem. Biophys. Res. Commun. 290, 844850.
  • Hunt, G., and Thody, A.J. (1995). Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis. J. Endocrinol. 147, R1R4.
  • Im, S., Moro, O., Peng, F., Medrano, E.E., Cornelius, J., Babcock, G., Nordlund, J.J., and Abdel-Malek, Z.A. (1998). Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res. 58, 4754.
  • Ito, S. (2003). A chemist's view of melanogenesis. Pigment Cell Res. 16, 230236.
  • Jimenez-Cervantes, C., Germer, S., Gonzalez, P., Sanchez, J., Sanchez, C.O., and Garcia-Borron, J.C. (2001a). Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett. 508, 4448.
  • Jimenez-Cervantes, C., Martinez-Esparza, M., Perez, C., Daum, N., Solano, F., and Garcia-Borron, J.C. (2001b). Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J. Cell Sci. 114, 23352344.
  • Jimenez-Cervantes, C., Olivares, C., Gonzalez, P., Morandini, R., Ghanem, G., and Garcia-Borron, J.C. (2001c). The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene. J. Invest. Dermatol. 117, 156158.
  • John, P.R., and Ramsay, M. (2002). Four novel variants in MC1R in red-haired South African individuals of European descent: S83P, Y152X, A171D, P256S. Hum. Mutat. 19, 461462.
  • John, P.R., Makova, K., Li, W.H., Jenkins, T., and Ramsay, M. (2003). DNA polymorphism and selection at the melanocortin-1 receptor gene in normally pigmented southern African individuals. Ann. N. Y. Acad. Sci. 994, 299306.
  • Kadekaro, A.L., Kavanagh, R., Kanto, H. et al. (2005). α -melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65, 42924299.
  • Kanetsky, P.A., Ge, F., Najarian, D., Swoyer, J., Panossian, S., Schuchter, L., Holmes, R., Guerry, D., and Rebbeck, T.R. (2004). Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol. Biomarkers Prev. 13, 808819.
  • Kenakin, T. (2001). Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J. 15, 598611.
  • Kiefer, L.L., Ittoop, O.R., Bunce, K., Truesdale, A.T., Willard, D.H., Nichols, J.S., Blanchard, S.G., Mountjoy, K., Chen, W.J., and Wilkinson, W.O. (1997). Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of lignad binding to the melanocortin receptors. Biochemistry 36, 20842090.
  • Kim, C.S., Lee, S.H., Kim, R.Y. et al. (2002). Identification of domains directing specificity of coupling to G-proteins for the melanocortin MC3 and MC4 receptors. J. Biol. Chem. 277, 3131031317.
  • Klungland, H., Vage, D.I., Gomez-Raya, L., Adalsteinsson, S., and Lien, S. (1995). The role of melanocyte-stimulating hormone (MSH) receptor in bovine coat color determination. Mamm. Genome 6, 636639.
  • Konda, Y., Gantz, I., DelValle, J., Shimoto, Y., Miwa, H., and Yamada, T. (1994). Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269, 1316213166.
  • Koppula, S.V., Robbins, L.S., Lu, D., Baack, E., White, C.R. Jr, Swanson, N.A., and Cone, R.D. (1997). Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects. Hum. Mutat. 9, 3036.
  • Labbe, O., Desarnaud, F., Eggerickx, D., Vassart, G., and Parmentier, M. (1994). Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33, 45434549.
  • Leonard, J.H., Marks, L.H., Chen, W., Cook, A.L., Boyle, G.M., Smit, D.J., Brown, D.L., Stow, J.L., Parsons, P.G., and Sturm, R.A. (2003). Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies. Pigment Cell Res. 16, 198207.
  • Lerner, A.B., and McGuire, J.S. (1961). Effect of alpha- and betamelanocyte stimulating hormones on the skin colour of man. Nature 189, 176179.
  • Ling, M.K., Lagerstrom, M.C., Fredriksson, R., Okimoto, R., Mundy, N.I., Takeuchi, S., and Schioth, H.B. (2003). Association of feather colour with constitutively active melanocortin 1 receptors in chicken. Eur. J. Biochem. 270, 14411449.
  • Loir, B., Bouchard, B., Morandini, R., Del, M.V., Deraemaecker, R., Garcia-Borron, J.C., and Ghanem, G. (1997). Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells. Eur. J. Biochem. 244, 923930.
  • Loir, B., Perez, S.C., Ghanem, G., Lozano, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (1999). Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study. Cell. Mol. Biol. (Noisy-le-grand) 45, 10831092.
  • Lu, D., Willard, D., Patel, I.R. et al. (1994). Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799802.
  • Lu, D., Vage, D.I., and Cone, R.D. (1998a). A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. Mol. Endocrinol. 12, 592604.
  • Lu, D., Haskell-Luevano, C., Vage, D.I., and Cone, R.D. (1998b). Functional variants of the MSH receptor (MC1-R), agouti, and their effects on mammalian pigmentation. In G Proteins, Receptors, and Disease, A.M.Spiegel, ed. (Totowa, NJ: Humana Press), pp. 231259.
  • Luttrell, L.M., and Lefkowitz, R.J. (2002). The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455465.
  • Mandrika, I., Petrovska, R., and Wikberg, J. (2005). Melanocortin receptors form constitutive homo- and heterodimers. Biochem. Biophys. Res. Commun. 326, 349354.
  • Martinez-Esparza, M., Jimenez-Cervantes, C., Beermann, F., Aparicio, P., Lozano, J.A., and Garcia-Borron, J.C. (1997). Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J. Biol. Chem. 272, 39673972.
  • Martinez-Esparza, M., Jimenez-Cervantes, C., Solano, F., Lozano, J.A., and Garcia-Borron, J.C. (1998). Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells. Eur. J. Biochem. 255, 139146.
  • Martinez-Esparza, M., Solano, F., and Garcia-Borron, J.C. (1999). Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. Cell. Mol. Biol. (Noisy-le-grand) 45, 9911000.
  • Martinez-Esparza, M., Ferrer, C., Castells, M.T., Garcia-Borron, J.C., and Zuasti, A. (2001). Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation. Int. J. Biochem. Cell Biol. 33, 971983.
  • Matichard, E., Verpillat, P., Meziani, R. et al. (2004). Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J. Med. Genet. 41, e13.
  • Miller, M.W., Duhl, D.M., Vrieling, H., Cordes, S.P., Ollmann, M.M., Winkes, B.M., and Barsh, G.S. (1993). Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7, 454467.
  • Milligan, G. (2001). Oligomerisation of G-protein-coupled receptors. J. Cell Sci. 114, 12651271.
  • Minneman, K.P. (2001). Splice variants of G protein-coupled receptors. Mol. Interv. 1, 108116.
  • Miserey-Lenkei, S., Parnot, C., Bardin, S., Corvol, P., and Clauser, E. (2002). Constitutive internalization of constitutively active angiotensin II AT1A receptor mutants is blocked by inverse agonists. J. Biol. Chem. 277, 58915901.
  • Moro, O., Ideta, R., and Ifuku, O. (1999). Characterization of the promoter region of the human melanocortin-1 receptor (MC1R) gene. Biochem. Biophys. Res. Commun. 262, 452460.
  • Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., and Cone, R.D. (1992). The cloning of a family of genes that encode the melanocortin receptors. Science 257, 12481251.
  • Mountjoy, K.G., Kong, P.L., Taylor, J.A., Willard, D.H., and Wilkison, W.O. (2001). Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol. Genomics 5, 1119.
  • Nappi, A.J., and Vass, E. (1996). Hydrogen peroxide generation associated with the oxidations of the eumelanin precursors 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Melanoma Res. 6, 341349.
  • Newton, J.M., Wilkie, A.L., He, L., Jordan, S.A., Metallinos, D.L., Holmes, N.G., Jackson, I.J., and Barsh, G.S. (2000). Melanocortin 1 receptor variation in the domestic dog. Mamm. Genome 11, 2430.
  • Ng, P.C., and Henikoff, S. (2001). Predicting deleterious amino acid substitutions. Genome Res. 11, 863874.
  • Ng, P.C., and Henikoff, S. (2002). Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12, 436446.
  • Nijenhuis, W.A., Oosterom, J., and Adan, R.A. (2001). AgRP(83–132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15, 164171.
  • Nishigori, C., Hattori, Y., and Toyokuni, S. (2004). Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox Signal. 6, 561570.
  • Ollmann, M.M., Lamoreux, M.L., Wilson, B.D., and Barsh, G.S. (1998). Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 12, 316330.
  • Palczewski, K., Kumasaka, T., Hori, T. et al. (2000). Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739745.
  • Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F., O'Gorman, L.E., Green, A.C., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176186.
  • Parnot, C., Miserey-Lenkei, S., Bardin, S., Corvol, P., and Clauser, E. (2002). Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13, 336343.
  • Pastorino, L., Cusano, R., Bruno, W., Lantieri, F., Origone, P., Barile, M., Gliori, S., Shepherd, G.A., Sturm, R.A., and Bianchi-Scarra, G. (2004). Novel MC1R variants in Ligurian melanoma patients and controls. Hum. Mutat. 24, 103.
  • Peng, S., Lu, X.M., Luo, H.R., Xiang-Yu, J.G., and Zhang, Y.P. (2001). Melanocortin-1 receptor gene variants in four Chinese ethnic populations. Cell Res. 11, 8184.
  • Pitcher, J.A., Freedman, N.J., and Lefkowitz, R.J. (1998). G protein-coupled receptor kinases. Annu. Rev. Biochem. 67, 653692.
  • Prusis, P., Frandberg, P.A., Muceniece, R., Kalvinsh, I., and Wikberg, J.E. (1995). A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. Biochem. Biophys. Res. Commun. 210, 205210.
  • Prusis, P., Schioth, H.B., Muceniece, R., Herzyk, P., Afshar, M., Hubbard, R.E., and Wikberg, J.E. (1997). Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. J. Mol. Graph. Model. 15, 307317, 334.
  • Qanbar, R., and Bouvier, M. (2003). Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol. Ther. 97, 133.
  • Raffin-Sanson, M.L., de Keyzer, Y., and Bertagna, X. (2003). Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur. J. Endocrinol. 149, 7990.
  • Rana, B.K., Hewett-Emmett, D., Jin, L. et al. (1999). High polymorphism at the human melanocortin 1 receptor locus. Genetics 151, 15471557.
  • Rees, J.L. (2003). Genetics of hair and skin color. Annu. Rev. Genet. 37, 6790.
  • Ringholm, A., Klovins, J., Rudzish, R., Phillips, S., Rees, J.L., and Schioth, H.B. (2004). Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J. Invest. Dermatol. 123, 917923.
  • Robbins, L.S., Nadeau, J.H., Johnson, K.R., Kelly, M.A., Roselli-Rehfuss, L., Baack, E., Mountjoy, K.G., and Cone, R.D. (1993). Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827834.
  • Robinson, S.J., and Healy, E. (2002). Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21, 80378046.
  • Roselli-Rehfuss, L., Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Low, M.J., Tatro, J.B., Entwistle, M.L., Simerly, R.B., and Cone, R.D. (1993). Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl Acad. Sci. USA 90, 88568860.
  • Rouzaud, F., Annereau, J.P., Valencia, J.C., Costin, G.E., and Hearing, V.J. (2003). Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist. FASEB J. 17, 21542156.
  • Rouzaud, F., Kadekaro, A.L., Abdel-Malek, Z.A., and Hearing, V.J. (2005). MC1R and the response of melanocytes to ultraviolet radiation. Mutat. Res. 571, 133152.
  • Sabatier, N., Caquineau, C., Dayanithi, G., Bull, P., Douglas, A.J., Guan, X.M., Jiang, M., Van der Ploeg, L., and Leng, G. (2003). Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J. Neurosci. 23, 1035110358.
  • Sakai, C., Ollmann, M., Kobayashi, T., Abdel-Malek, Z., Muller, J., Vieira, W.D., Imokawa, G., Barsh, G.S., and Hearing, V.J. (1997). Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO J. 16, 35443552.
  • Salazar-Onfray, F., Lopez, M., Lundqvist, A. et al. (2002). Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br. J. Cancer 87, 414422.
  • Sanchez, M.J., Olivares, S.C., Ghanem, G., Haycock, J., Lozano Teruel, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2002). Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur. J. Biochem. 269, 61336141.
  • Sanchez Mas, J., Gerritsen, I., Hahmann, C., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2003). Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Res. 16, 540547.
  • Sanchez-Laorden, B.L., Sanchez-Mas, J., Martínez-Alonso, E., Martínez-Menárguez, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2005a). Dimerization of the human melanocortin 1 receptor. Functional consequences and dominant-negative effects. J. Invest. Dermatol. (in press).
  • Sanchez-Laorden, B.L., Sanchez-Mas, J., Turpin, M.C., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2005b). Variant amino acids in different domains of the human melanocortin 1 receptor impair cell surface expression. Mol. Cell. Biol. (in press).
  • Sanchez-Mas, J., Hahmann, C., Gerritsen, I., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2004). Agonist-independent, high constitutive activity of the human melanocortin 1 receptor. Pigment Cell Res. 17, 386395.
  • Sanchez-Mas, J., Guillo, L.A., Zanna, P., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2005a). Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors. Mol. Endocrinol. 19, 10351048.
  • Sanchez-Mas, J., Sanchez-Laorden, B.L., Guillo, L.A., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2005b). The melanocortin-1 receptor carboxyl terminal pentapeptide is essential for MC1R function and expression on the cell surface. Peptides 26, 18481857.
  • Schiller, M., Brzoska, T., Bohm, M., Metze, D., Scholzen, T.E., Rougier, A., and Luger, T.A. (2004). Solar-simulated ultraviolet radiation-induced upregulation of the melanocortin-1 receptor, proopiomelanocortin, and alpha-melanocyte-stimulating hormone in human epidermis in vivo. J. Invest. Dermatol. 122, 468476.
  • Schioth, H.B., Petersson, S., Muceniece, R., Szardenings, M., and Wikberg, J.E. (1997). Deletions of the N-terminal regions of the human melanocortin receptors. FEBS Lett. 410, 223228.
  • Schioth, H.B., Phillips, S.R., Rudzish, R., Birch-Machin, M.A., Wikberg, J.E., and Rees, J.L. (1999). Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem. Biophys. Res. Commun. 260, 488491.
  • Schioth, H.B., Haitina, T., Ling, M.K., Ringholm, A., Fredriksson, R., Cerda-Reverter, J.M., and Klovins, J. (2005). Evolutionary conservation of the structural, pharmacological, and genomic characteristics of the melanocortin receptor subtypes. Peptides 26, 18861900.
  • Schulein, R., Hermosilla, R., Oksche, A., Dehe, M., Wiesner, B., Krause, G., and Rosenthal, W. (1998). A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells. Mol. Pharmacol. 54, 525535.
  • Scott, M.C., Suzuki, I., and Abdel-Malek, Z.A. (2002a). Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res. 15, 433439.
  • Scott, M.C., Wakamatsu, K., Ito, S. et al. (2002b). Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J. Cell Sci. 115, 23492355.
  • Searle, A.G. (1968). An extension series in the mouse. J. Hered. 59, 341342.
  • Seifert, R., and Wenzel-Seifert, K. (2002). Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch. Pharmacol. 366, 381416.
  • Shinyama, H., Masuzaki, H., Fang, H., and Flier, J.S. (2003). Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144, 13011314.
  • Siegrist, W., and Eberle, A.N. (1993). Homologous regulation of the MSH receptor in melanoma cells. J. Recept. Res. 13, 263281.
  • Siegrist, W., Solca, F., Stutz, S., Giuffre, L., Carrel, S., Girard, J., and Eberle, A.N. (1989). Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. Cancer Res. 49, 63526358.
  • Siegrist, W., Stutz, S., and Eberle, A.N. (1994). Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res. 54, 26042610.
  • Siegrist, W., Willard, D.H., Wilkison, W.O., and Eberle, A.N. (1996). Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors. Biochem. Biophys. Res. Commun. 218, 171175.
  • Siegrist, W., Drozdz, R., Cotti, R., Willard, D.H., Wilkison, W.O., and Eberle, A.N. (1997). Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. J. Recept. Signal Transduct. Res. 17, 7598.
  • Siracusa, L.D. (1994). The agouti gene: turned on to yellow. Trends Genet. 10, 423428.
  • Slominski, A. (1998). Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp. Dermatol. 7, 213216.
  • Slominski, A., Paus, R., and Wortsman, J. (1993). On the potential role of proopiomelanocortin in skin physiology and pathology. Mol. Cell. Endocrinol. 93, C1C6.
  • Smith, R., Healy, E., Siddiqui, S. et al. (1998). Melanocortin 1 receptor variants in an Irish population. J. Invest. Dermatol. 111, 119122.
  • Smith, A.G., Box, N.F., Marks, L.H., Chen, W., Smit, D.J., Wyeth, J.R., Huttley, G.A., Easteal, S., and Sturm, R.A. (2001). The human melanocortin-1 receptor locus: analysis of transcription unit, locus polymorphism and haplotype evolution. Gene 281, 8194.
  • Solca, F., Siegrist, W., Drozdz, R., Girard, J., and Eberle, A.N. (1989). The receptor for alpha-melanotropin of mouse and human melanoma cells. Application of a potent alpha-melanotropin photoaffinity label. J. Biol. Chem. 264, 1427714281.
  • Starowicz, K., and Przewlocka, B. (2003). The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 73, 823847.
  • Strader, C.D., Fong, T.M., Tota, M.R., Underwood, D., and Dixon, R.A. (1994). Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101132.
  • Sturm, R.A. (2002). Skin colour and skin cancer – MC1R, the genetic link. Melanoma Res. 12, 405416.
  • Sturm, R.A., Duffy, D.L., Box, N.F., Newton, R.A., Shepherd, A.G., Chen, W., Marks, L.H., Leonard, J.H., and Martin, N.G. (2003). Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann. N. Y. Acad. Sci. 994, 348358.
  • Subramaniam, S., and Henderson, R. (1999). Electron crystallography of bacteriorhodopsin with millisecond time resolution. J. Struct. Biol. 128, 1925.
  • Suzuki, I., Tada, A., Ollmann, M.M., Barsh, G.S., Im, S., Lamoreux, M.L., Hearing, V.J., Nordlund, J.J., and Abdel-Malek, Z.A. (1997). Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J. Invest. Dermatol. 108, 838842.
  • Tan, C.P., McKee, K.K., Weinberg, D.H., MacNeil, T., Palyha, O.C., Feighner, S.D., Hreniuk, D.L., Van Der Ploeg, L.H., MacNeil, D.J., and Howard, A.D. (1999). Molecular analysis of a new splice variant of the human melanocortin-1 receptor. FEBS Lett. 451, 137141.
  • Tarnow, P., Schoneberg, T., Krude, H., Gruters, A., and Biebermann, H. (2003). Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity. J. Biol. Chem. 278, 4866648673.
  • Vage, D.I., Lu, D., Klungland, H., Lien, S., Adalsteinsson, S., and Cone, R.D. (1997). A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat. Genet. 15, 311315.
  • Valverde, P., Healy, E., Jackson, I., Rees, J.L., and Thody, A.J. (1995). Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11, 328330.
  • Vance, K.W., and Goding, C.R. (2004). The transcription network regulating melanocyte development and melanoma. Pigment Cell Res. 17, 318325.
  • VanLeeuwen, D., Steffey, M.E., Donahue, C., Ho, G., and MacKenzie, R.G. (2003). Cell surface expression of the melanocortin-4 receptor is dependent on a C-terminal di-isoleucine sequence at codons 316/317. J. Biol. Chem. 278, 1593515940.
  • Varga, J.M., Moellmann, G., Fritsch, P., Godawska, E., and Lerner, A.B. (1976). Association of cell surface receptors for melanotropin with the Golgi region in mouse melanoma cells. Proc. Natl Acad. Sci. USA 73, 559562.
  • Voisey, J., and Van Daal, A. (2002). Agouti: from mouse to man, from skin to fat. Pigment Cell Res. 15, 1018.
  • Wachira, S.J., Hughes-Darden, C.A., Taylor, C.V., Ochillo, R., and Robinson, T.J. (2003). Evidence for the interaction of protein kinase C and melanocortin 3-receptor signaling pathways. Neuropeptides 37, 201210.
  • Wakamatsu, K., Graham, A., Cook, D., and Thody, A.J. (1997). Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res. 10, 288297.
  • Wallin, E., and von Heijne, G. (1995). Properties of N-terminal tails in G-protein coupled receptors: a statistical study. Protein Eng. 8, 693698.
  • Willard, D.H., Bodnar, W., Harris, C. et al. (1995). Agouti structure and function: characterization of a potent alpha-melanocyte stimulating hormone receptor antagonist. Biochemistry 34, 1234112346.
  • Wilson, B.D., Ollmann, M.M., Kang, L., Stoffel, M., Bell, G.I., and Barsh, G.S. (1995). Structure and function of ASP, the human homolog of the mouse agouti gene. Hum. Mol. Genet. 4, 223230.
  • Wong, W., and Minchin, R.F. (1996). Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells. Int. J. Biochem. Cell Biol. 28, 12231232.
  • Wong, T.H., and Rees, J.L. (2005). The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides 26, 19651971.
  • Yang, Y., Dickinson, C., Haskell-Luevano, C., and Gantz, I. (1997a). Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor. J. Biol. Chem. 272, 2300023010.
  • Yang, Y.K., Ollmann, M.M., Wilson, B.D., Dickinson, C., Yamada, T., Barsh, G.S., and Gantz, I. (1997b). Effects of recombinant agouti-signaling protein on melanocortin action. Mol. Endocrinol. 11, 274280.